Rituximab in Children with Steroid-Dependent Nephrotic Syndrome: A Multicenter, Open-Label, Noninferiority, Randomized Controlled Trial

Steroid-dependent nephrotic syndrome (SDNS) carries a high risk of toxicity from steroids or steroid-sparing agents. This open-label, noninferiority, randomized controlled trial at four sites in Italy tested whether rituximab is noninferior to steroids in maintaining remission in juvenile SDNS. We e...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Am Soc Nephrol
Hlavní autoři: Ravani, Pietro, Rossi, Roberta, Bonanni, Alice, Quinn, Robert R., Sica, Felice, Bodria, Monica, Pasini, Andrea, Montini, Giovanni, Edefonti, Alberto, Belingheri, Mirco, De Giovanni, Donatella, Barbano, Giancarlo, Degl’Innocenti, Ludovica, Scolari, Francesco, Murer, Luisa, Reiser, Jochen, Fornoni, Alessia, Ghiggeri, Gian Marco
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Nephrology 2015
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552120/
https://ncbi.nlm.nih.gov/pubmed/25592855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2014080799
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky